Cargando…

Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review

Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosutinib treatment.

Detalles Bibliográficos
Autores principales: Liu, Qiuying (Selina), Ass'ad, Nour Ali, Arana Yi, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145267/
https://www.ncbi.nlm.nih.gov/pubmed/34094551
http://dx.doi.org/10.1002/ccr3.3164
_version_ 1783697134937178112
author Liu, Qiuying (Selina)
Ass'ad, Nour Ali
Arana Yi, Cecilia
author_facet Liu, Qiuying (Selina)
Ass'ad, Nour Ali
Arana Yi, Cecilia
author_sort Liu, Qiuying (Selina)
collection PubMed
description Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosutinib treatment.
format Online
Article
Text
id pubmed-8145267
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81452672021-06-03 Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review Liu, Qiuying (Selina) Ass'ad, Nour Ali Arana Yi, Cecilia Clin Case Rep Case Reports Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosutinib treatment. John Wiley and Sons Inc. 2021-05-07 /pmc/articles/PMC8145267/ /pubmed/34094551 http://dx.doi.org/10.1002/ccr3.3164 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Liu, Qiuying (Selina)
Ass'ad, Nour Ali
Arana Yi, Cecilia
Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
title Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
title_full Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
title_fullStr Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
title_full_unstemmed Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
title_short Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
title_sort bosutinib‐associated interstitial lung disease and pleural effusion: a case report and literature review
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145267/
https://www.ncbi.nlm.nih.gov/pubmed/34094551
http://dx.doi.org/10.1002/ccr3.3164
work_keys_str_mv AT liuqiuyingselina bosutinibassociatedinterstitiallungdiseaseandpleuraleffusionacasereportandliteraturereview
AT assadnourali bosutinibassociatedinterstitiallungdiseaseandpleuraleffusionacasereportandliteraturereview
AT aranayicecilia bosutinibassociatedinterstitiallungdiseaseandpleuraleffusionacasereportandliteraturereview